Dosimetry with the TruView gel on a 0.35 T MR-Linac: A feasibility study

Abstract

The purpose of this work is to assess the feasibility of performing dosimetry with the TruView (ModusQA, London, Ontario, Canada) MTB Fricke gel by MRI reading on a low field MR-Linac (0.35 T). Radiochromic TruView gels were manufactured at IRSN. A 4 echoes time (TE) single-shot fast spin echo sequence (HASTE) was used for 2D images acquisitions. Raw MRI images were denoised (MP-PCA) and transversal relaxation rates (R2) maps were extracted using a homemade Matlab routine. Temperature influences on R2 as well as gel homogeneity were investigated. A dosimetric evaluation of the TruView gel was conducted implying four gels made from the same batch, with three of them dedicated to calibration, and the fourth one received a simple dosimetric plan. Results showed the TruView gel to be sensitive to temperature drift. A protocol was thus developed to ensure thermal stability with the use of a dedicated temperature-controlled water bath. An inhomogeneity that manifests as a R2 increase near the air/gel interface was found to cause a 4% amplitude deviation in R2 along unirradiated gels. Air sealing drastically reduced the inhomogeneity. Dose versus R2 calibration was established. TruView gel sensitivity was found to be low (0.0093 Gy−1 s−1). 1D and 2D comparison to planned dose distribution displayed overall agreement with global gamma index (5%/3 mm) evaluation with an 87 % passing rate. Main discrepancies in the low and gradient dose regions were attributable to the calibration range and diffusion effects. This study demonstrated the feasibility of using the TruView gel for dosimetric evaluation on a low field MR-Linac. The protocol developed needs to be extended to a full 3D evaluation to enable patient QA and may require modifications to the gel formulation to increase its overall sensitivity and ensure limited dependence on temperature drift.